Stock Price Forecast

April 24, 2024


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading 10x Genomics, Inc. chart...

About the Company

10x Genomics, Inc. is an American biotechnology company that designs and manufactures gene sequencing technology used in scientific research. It was founded in 2012 by Serge Saxonov, Ben Hindson, and Kevin Ness.

Exchange

Nasdaq

$618M

Total Revenue

500

Employees

$3B

Market Capitalization

-12.56

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $TXG News

10x Genomics

2d ago, source: Forbes

10X Genomics, Inc. is a life science technology company, which engages in building products to interrogate, understand and master biology. Its integrated solutions include single cell ...

The Analyst Landscape: 4 Takes On 10x Genomics

8d ago, source:

Analysts have set 12-month price targets for 10x Genomics, revealing an average target of $54.5, a high estimate of $63.00, ...

10x Genomics Inc Ordinary Shares - Class A

15d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

10x Genomics Commercially Launches Visium HD Spatial Gene Expression Assay

1mon ago, source: Stockhouse

PLEASANTON, Calif., March 26, 2024 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today the commercial availability of its Visium HD Spatial ...

First Week of TXG June 21st Options Trading

7d ago, source: Nasdaq

Investors in 10x Genomics Inc (Symbol: TXG) saw new options begin trading this week, for the June 21st expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the TXG ...

Analysts Offer Insights on Healthcare Companies: 10x Genomics (TXG) and LivaNova (LIVN)

16d ago, source:

Analysts have been eager to weigh in on the Healthcare sector with new ratings on 10x Genomics (TXG – Research Report) and LivaNova (LIVN – ...

10x Genomics Inc.

1mon ago, source: Wall Street Journal

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

10x Genomics Commercially Launches Visium HD Spatial Gene Expression Assay

1mon ago, source: Yahoo Finance

March 26, 2024 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today the commercial availability of its Visium HD Spatial Gene Expression ...

10x Genomics Inc Ordinary Shares - Class A

1mon ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

10x Genomics Inc.

2mon ago, source: Barron's

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

10x Genomics, Inc. (TXG)

1mon ago, source: Yahoo Finance

10x Genomics, Inc. (NASDAQ:TXG) Q4 2023 Earnings Call Transcript February 15, 2024 10x Genomics, Inc. misses on earnings expectations. Reported EPS is $-0.41 EPS, expectations were $-0.36. 10x ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...